SignatureFD’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-102
Closed -$2.76K 3334
2024
Q2
$2.76K Buy
102
+57
+127% +$1.19K ﹤0.01% 2675
2024
Q1
$824 Buy
+45
New +$714 ﹤0.01% 2972
2023
Q4
Sell
-361
Closed -$5.41K 3305
2023
Q3
$5.41K Buy
361
+321
+803% +$6.68K ﹤0.01% 2461
2023
Q2
$1.3K Hold
40
﹤0.01% 2916
2023
Q1
$1.56K Sell
40
-79
-66% -$3.86K ﹤0.01% 2873
2022
Q4
$6.29K Buy
119
+7
+6% +$341 ﹤0.01% 2359
2022
Q3
$5K Buy
112
+72
+180% +$3.1K ﹤0.01% 2483
2022
Q2
$1K Sell
40
-140
-78% -$5.09K ﹤0.01% 3048
2022
Q1
$7K Buy
180
+147
+445% +$5.17K ﹤0.01% 2371
2021
Q4
$1K Buy
33
+6
+22% +$300 ﹤0.01% 3034
2021
Q3
$1K Buy
27
+17
+170% +$890 ﹤0.01% 2964
2021
Q2
$0 Buy
+10
New +$510 ﹤0.01% 3089

Other funds holding SILK

SignatureFD's SILK Position: Q3 2024 in Review

SignatureFD sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 102 shares — an estimated $2.76K sold.

SignatureFD first reported a position in SILK in Q2 2021 and held it in 12 quarters. The position peaked at $7K in Q1 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • SignatureFD reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • SignatureFD sold 102 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $2.76K.
  • SignatureFD first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • SignatureFD's Silk Road Medical, Inc. Common Stock position peaked at $7K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on SignatureFD's 13F filing for Q3 2024, filed 21 Oct 2024.